BioVie Inc. - Equity Warrant

Introduction

This page provides a comprehensive analysis of the known insider trading history of Steve Gorlin. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

See Highest Ranking Insiders
Companies with Reported Insider Positions

The SEC filings indicate Steve Gorlin has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:BIVI / BioVie Inc. Director 46,358
US:IBRX / ImmunityBio, Inc. Director 100,000
US:PTE / PolarityTE Inc Director 31,018
US:OTRKQ / Ontrak, Inc. Director 100,000
US:MDVX / Medovex Corp. 1,640,704
US:MDXG / MiMedx Group, Inc. Director 451,857
US:DARA / DARA Biosciences, Inc. Director 50,000
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Steve Gorlin. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases BIVIW / BioVie Inc. - Equity Warrant - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in BIVIW / BioVie Inc. - Equity Warrant. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Max		 Price at
Max		 Max
Profit ($)		 Max Return (%)
2020-11-03 BIVI GORLIN STEVE 2,430 7.9500 243 79.5000 19,318 92 44.81 -8,429 -43.63
2020-10-30 BIVI GORLIN STEVE 2,570 7.9700 257 79.7000 20,483
2020-10-21 BIVI GORLIN STEVE 5,000 9.1900 500 91.9000 45,950
2020-10-15 BIVI GORLIN STEVE 5,000 10.0100 500 100.1000 50,050
2020-10-15 BIVI GORLIN STEVE 5,000 10.1000 500 101.0000 50,500
2020-10-15 BIVI GORLIN STEVE 4,000 10.1900 400 101.9000 40,760
2020-10-15 BIVI GORLIN STEVE 1,000 10.1800 100 101.8000 10,180
2020-10-15 BIVI GORLIN STEVE 100 10.2700 10 102.7000 1,027
2020-10-09 BIVI GORLIN STEVE 282 9.6100 28 96.1000 2,710
2020-10-07 BIVI GORLIN STEVE 4,718 9.4200 472 94.2000 44,444
2020-09-22 BIVI GORLIN STEVE 15,000 10.0000 1,500 100.0000 150,000

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

BIVIW / BioVie Inc. - Equity Warrant Insider Trades
Insider Sales BIVIW / BioVie Inc. - Equity Warrant - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in BIVIW / BioVie Inc. - Equity Warrant. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Min		 Price at
Min		 Max Loss
Avoided ($)		 Max Loss
Avoided (%)
2023-12-01 BIVI GORLIN STEVE 75,680 1.6900 7,568 16.9000 127,899 248 0.2939 -125,675 -98.26
2023-09-05 BIVI GORLIN STEVE 8,560 3.0500 856 30.5000 26,108

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

BIVIW / BioVie Inc. - Equity Warrant Insider Trades
Insider Purchases IBRX / ImmunityBio, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in BIVIW / BioVie Inc. - Equity Warrant. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Max		 Price at
Max		 Max
Profit ($)		 Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

IBRX / ImmunityBio, Inc. Insider Trades
Insider Sales IBRX / ImmunityBio, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in BIVIW / BioVie Inc. - Equity Warrant. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Min		 Price at
Min		 Max Loss
Avoided ($)		 Max Loss
Avoided (%)
2018-11-29 NK GORLIN STEVE 34,019 1.6986 34,019 1.6986 57,785 731 9.6700 271,180 469.30
2018-11-29 NK GORLIN STEVE 138,349 1.6500 138,349 1.6500 228,276
2018-11-28 NK GORLIN STEVE 17,140 1.7576 17,140 1.7576 30,125
2018-11-27 NK GORLIN STEVE 100,000 1.7520 100,000 1.7520 175,200
2018-11-23 NK GORLIN STEVE 9,312 2.0100 9,312 2.0100 18,717
2018-11-21 NK GORLIN STEVE 22,900 2.0182 22,900 2.0182 46,217
2018-11-14 NK GORLIN STEVE 115,930 2.2058 115,930 2.2058 255,718
2018-11-13 NK GORLIN STEVE 33,300 2.3990 33,300 2.3990 79,887
2018-11-12 NK GORLIN STEVE 47,050 2.4328 47,050 2.4328 114,463
2018-08-27 NK GORLIN STEVE 18,300 3.0854 18,300 3.0854 56,463
2018-08-24 NK GORLIN STEVE 10,225 3.0651 10,225 3.0651 31,341
2018-08-23 NK GORLIN STEVE 21,475 3.0598 21,475 3.0598 65,709
2018-06-07 NK GORLIN STEVE 26,957 3.6582 26,957 3.6582 98,614
2018-06-06 NK GORLIN STEVE 23,574 3.7869 23,574 3.7869 89,272
2018-06-05 NK GORLIN STEVE 28,925 3.7455 28,925 3.7455 108,339
2018-05-30 NK GORLIN STEVE 2,724 3.8781 2,724 3.8781 10,564
2018-05-29 NK GORLIN STEVE 1,500 3.8900 1,500 3.8900 5,835
2018-05-29 NK GORLIN STEVE 500 3.9000 500 3.9000 1,950
2018-05-29 NK GORLIN STEVE 100 3.8950 100 3.8950 390
2018-05-25 NK GORLIN STEVE 3,400 3.9700 3,400 3.9700 13,498
2018-05-25 NK GORLIN STEVE 200 3.9800 200 3.9800 796
2018-05-24 NK GORLIN STEVE 303 3.9600 303 3.9600 1,200
2018-05-22 NK GORLIN STEVE 8,546 3.8100 8,546 3.8100 32,560
2018-05-22 NK GORLIN STEVE 8,546 3.9119 8,546 3.9119 33,431
2018-05-21 NK GORLIN STEVE 5,557 3.9000 5,557 3.9000 21,672
2018-05-21 NK GORLIN STEVE 5,557 3.9980 5,557 3.9980 22,217
2018-05-18 NK GORLIN STEVE 15,971 3.9705 15,971 3.9705 63,413
2017-09-13 NK GORLIN STEVE 39,604 5.9269 39,604 5.9269 234,729
2017-09-12 NK GORLIN STEVE 35,811 6.0270 35,811 6.0270 215,833
2017-09-11 NK GORLIN STEVE 53,307 6.0305 53,307 6.0305 321,468
2017-09-08 NK GORLIN STEVE 14,723 6.1208 14,723 6.1208 90,117
2015-08-21 NK GORLIN STEVE 450,000 23.0000 450,000 23.0000 10,350,000

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

IBRX / ImmunityBio, Inc. Insider Trades
Insider Purchases IVRN / Innoveren Scientific Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in BIVIW / BioVie Inc. - Equity Warrant. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Max		 Price at
Max		 Max
Profit ($)		 Max Return (%)
2017-08-21 MDVX GORLIN STEVE 50,000 1.2500 50,000 1.2500 62,500 24 1.2600 500 0.80
2017-08-16 MDVX GORLIN STEVE 200,000 0.9000 200,000 0.9000 180,000
2017-06-28 MDVX GORLIN STEVE 3,000 0.8700 3,000 0.8700 2,610
2017-06-28 MDVX GORLIN STEVE 2,000 0.8800 2,000 0.8800 1,760
2017-06-14 MDVX GORLIN STEVE 5,000 0.9700 5,000 0.9700 4,850
2017-06-07 MDVX GORLIN STEVE 5,000 0.9400 5,000 0.9400 4,700
2017-06-07 MDVX GORLIN STEVE 15,000 0.9500 15,000 0.9500 14,250
2017-06-07 MDVX GORLIN STEVE 5,000 0.9600 5,000 0.9600 4,800
2017-06-07 MDVX GORLIN STEVE 5,000 0.9800 5,000 0.9800 4,900
2017-02-09 MDVX GORLIN STEVE 144,230 1.0400 144,230 1.0400 149,999
2016-12-01 MDVX GORLIN STEVE 257,143 1.7500 257,143 1.7500 450,000
2016-12-01 MDVX GORLIN STEVE 314,286 1.7500 314,286 1.7500 550,000
2016-02-16 MDVX GORLIN STEVE 552,041 1.8114 552,041 1.8114 999,967
2015-12-10 MDVX GORLIN STEVE 20,000 1.0875 20,000 1.0875 21,750
2015-12-09 MDVX GORLIN STEVE 20,000 1.1459 20,000 1.1459 22,918
2015-11-24 MDVX GORLIN STEVE 40,000 1.4490 40,000 1.4490 57,960

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

IVRN / Innoveren Scientific Inc. Insider Trades
Insider Sales IVRN / Innoveren Scientific Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in BIVIW / BioVie Inc. - Equity Warrant. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Min		 Price at
Min		 Max Loss
Avoided ($)		 Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

IVRN / Innoveren Scientific Inc. Insider Trades
Insider Purchases MDXG / MiMedx Group, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in BIVIW / BioVie Inc. - Equity Warrant. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Max		 Price at
Max		 Max
Profit ($)		 Max Return (%)
2010-04-01 MDXG.OB GORLIN STEVE 500 1.4500 500 1.4500 725 731 1.15 -150 -20.69
2010-04-01 MDXG.OB GORLIN STEVE 2,500 1.5000 2,500 1.5000 3,750
2010-04-01 MDXG.OB GORLIN STEVE 2,000 1.5200 2,000 1.5200 3,040
2010-03-30 MDXG.OB GORLIN STEVE 2,000 1.5500 2,000 1.5500 3,100
2010-03-30 MDXG.OB GORLIN STEVE 2,000 1.5700 2,000 1.5700 3,140
2010-03-26 MDXG.OB GORLIN STEVE 1,000 1.5700 1,000 1.5700 1,570
2009-12-10 MDXG.OB GORLIN STEVE 200 0.6800 200 0.6800 136
2009-12-09 MDXG.OB GORLIN STEVE 200 0.7000 200 0.7000 140
2009-12-08 MDXG.OB GORLIN STEVE 500 0.6500 500 0.6500 325
2009-12-07 MDXG.OB GORLIN STEVE 5,000 0.6500 5,000 0.6500 3,250
2009-12-07 MDXG.OB GORLIN STEVE 2,500 0.7000 2,500 0.7000 1,750
2009-11-19 MDXG.OB GORLIN STEVE 35,000 0.5000 35,000 0.5000 17,500
2009-11-06 MDXG.OB GORLIN STEVE 500 0.7800 500 0.7800 390
2009-11-05 MDXG.OB GORLIN STEVE 500 0.7800 500 0.7800 390
2009-10-23 MDXG.OB GORLIN STEVE 500 0.8000 500 0.8000 400
2009-10-22 MDXG.OB GORLIN STEVE 500 0.8000 500 0.8000 400
2009-10-02 MDXG.OB GORLIN STEVE 500 0.7500 500 0.7500 375
2009-10-02 MDXG.OB GORLIN STEVE 6,000 0.8000 6,000 0.8000 4,800
2009-10-02 MDXG.OB GORLIN STEVE 11,500 0.8500 11,500 0.8500 9,775
2009-10-01 MDXG.OB GORLIN STEVE 500 0.7500 500 0.7500 375
2009-09-30 MDXG.OB GORLIN STEVE 6,100 0.7500 6,100 0.7500 4,575
2009-09-29 MDXG.OB GORLIN STEVE 4,000 0.7500 4,000 0.7500 3,000
2009-09-28 MDXG.OB GORLIN STEVE 1,000 0.7500 1,000 0.7500 750
2009-09-25 MDXG.OB GORLIN STEVE 1,500 0.7500 1,500 0.7500 1,125
2009-09-24 MDXG.OB GORLIN STEVE 2,500 0.6900 2,500 0.6900 1,725
2009-09-23 MDXG.OB GORLIN STEVE 3,200 0.7000 3,200 0.7000 2,240
2009-09-22 MDXG.OB GORLIN STEVE 3,000 0.7000 3,000 0.7000 2,100
2009-09-21 MDXG.OB GORLIN STEVE 2,500 0.7000 2,500 0.7000 1,750
2009-09-18 MDXG.OB GORLIN STEVE 2,500 0.7000 2,500 0.7000 1,750
2009-09-18 MDXG.OB GORLIN STEVE 1,000 0.7000 1,000 0.7000 700
2009-09-17 MDXG.OB GORLIN STEVE 1,000 0.5900 1,000 0.5900 590
2009-09-17 MDXG.OB GORLIN STEVE 2,416 0.6000 2,416 0.6000 1,450
2009-09-16 MDXG.OB GORLIN STEVE 1,000 0.6000 1,000 0.6000 600
2009-09-15 MDXG.OB GORLIN STEVE 12,400 0.6000 12,400 0.6000 7,440
2009-09-14 MDXG.OB GORLIN STEVE 7,500 0.6000 7,500 0.6000 4,500
2009-09-10 MDXG.OB GORLIN STEVE 1,000 0.6000 1,000 0.6000 600
2009-09-09 MDXG.OB GORLIN STEVE 500 0.6000 500 0.6000 300
2009-09-09 MDXG.OB GORLIN STEVE 184 0.4500 184 0.4500 83

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

MDXG / MiMedx Group, Inc. Insider Trades
Insider Sales MDXG / MiMedx Group, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in BIVIW / BioVie Inc. - Equity Warrant. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Min		 Price at
Min		 Max Loss
Avoided ($)		 Max Loss
Avoided (%)
2013-05-16 MDXG GORLIN STEVE 30,000 6.4600 30,000 6.4600 193,800 111 3.849 -78,330 -40.42
2013-04-17 MDXG GORLIN STEVE 20,000 4.9900 20,000 4.9900 99,800
2012-11-06 MDXG GORLIN STEVE 22,700 2.8900 22,700 2.8900 65,603
2012-11-05 MDXG GORLIN STEVE 12,000 2.9000 12,000 2.9000 34,800
2012-11-05 MDXG GORLIN STEVE 18,450 2.8900 18,450 2.8900 53,320
2012-11-05 MDXG GORLIN STEVE 8,550 2.8700 8,550 2.8700 24,538
2012-11-02 MDXG GORLIN STEVE 20,000 2.9000 20,000 2.9000 58,000
2012-11-02 MDXG GORLIN STEVE 15,000 2.8800 15,000 2.8800 43,200
2012-11-02 MDXG GORLIN STEVE 3,300 2.8600 3,300 2.8600 9,438
2012-09-10 MDXG.OB GORLIN STEVE 72,300 2.7000 72,300 2.7000 195,210
2012-06-29 MDXG.OB GORLIN STEVE 1,000,000 1.5500 1,000,000 1.5500 1,550,000
2012-03-02 MDXG.OB GORLIN STEVE 250,000 1.0000 250,000 1.0000 250,000
2009-08-04 MDXG.OB GORLIN STEVE 450,504 0.0000 450,504 0.0000 0

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

MDXG / MiMedx Group, Inc. Insider Trades
Insider Purchases OTRKQ / Ontrak, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in BIVIW / BioVie Inc. - Equity Warrant. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Max		 Price at
Max		 Max
Profit ($)		 Max Return (%)
2018-06-15 CATS GORLIN STEVE 300 8.5900 300 8.5900 2,577 339
2018-06-15 CATS GORLIN STEVE 100 8.6400 100 8.6400 864
2018-06-15 CATS GORLIN STEVE 1,550 8.6000 1,550 8.6000 13,330
2018-06-15 CATS GORLIN STEVE 300 8.6500 300 8.6500 2,595
2018-06-15 CATS GORLIN STEVE 2,300 8.5900 2,300 8.5900 19,757
2018-06-15 CATS GORLIN STEVE 215 8.5700 215 8.5700 1,843
2018-06-15 CATS GORLIN STEVE 100 7.9200 100 7.9200 792
2018-06-15 CATS GORLIN STEVE 600 7.9300 600 7.9300 4,758
2018-06-15 CATS GORLIN STEVE 600 7.9100 600 7.9100 4,746
2018-06-15 CATS GORLIN STEVE 2,200 7.9400 2,200 7.9400 17,468
2018-06-15 CATS GORLIN STEVE 1,200 7.9100 1,200 7.9100 9,492
2018-06-15 CATS GORLIN STEVE 300 7.9500 300 7.9500 2,385
2018-06-15 CATS GORLIN STEVE 100 8.3400 100 8.3400 834
2018-06-15 CATS GORLIN STEVE 800 8.3500 800 8.3500 6,680
2018-06-15 CATS GORLIN STEVE 100 8.3800 100 8.3800 838
2018-06-15 CATS GORLIN STEVE 1,000 8.3900 1,000 8.3900 8,390
2018-06-15 CATS GORLIN STEVE 800 8.4000 800 8.4000 6,720
2018-06-15 CATS GORLIN STEVE 100 8.4100 100 8.4100 841
2018-06-15 CATS GORLIN STEVE 200 8.4700 200 8.4700 1,694
2018-06-15 CATS GORLIN STEVE 600 8.5000 600 8.5000 5,100
2018-06-15 CATS GORLIN STEVE 200 8.4500 200 8.4500 1,690
2018-06-15 CATS GORLIN STEVE 900 8.4600 900 8.4600 7,614
2018-06-15 CATS GORLIN STEVE 85 8.4800 85 8.4800 721
2018-06-15 CATS GORLIN STEVE 115 8.4900 115 8.4900 976
2018-06-15 CATS GORLIN STEVE 1,100 8.4700 1,100 8.4700 9,317
2018-06-15 CATS GORLIN STEVE 1,385 8.4900 1,385 8.4900 11,759
2018-06-15 CATS GORLIN STEVE 100 8.4500 100 8.4500 845
2018-06-15 CATS GORLIN STEVE 350 8.5000 350 8.5000 2,975
2018-06-15 CATS GORLIN STEVE 200 8.5800 200 8.5800 1,716
2018-06-15 CATS GORLIN STEVE 100 8.6300 100 8.6300 863
2018-06-15 CATS GORLIN STEVE 1,100 8.7100 1,100 8.7100 9,581
2018-06-15 CATS GORLIN STEVE 200 8.6700 200 8.6700 1,734
2018-06-15 CATS GORLIN STEVE 3,000 8.7000 3,000 8.7000 26,100
2018-06-15 CATS GORLIN STEVE 700 8.6900 700 8.6900 6,083
2018-06-15 CATS GORLIN STEVE 300 8.6300 300 8.6300 2,589
2018-06-15 CATS GORLIN STEVE 1,700 8.6800 1,700 8.6800 14,756
2015-10-16 CATS GORLIN STEVE 300,000 0.3000 300,000 0.3000 90,000
2014-12-22 CATS GORLIN STEVE 150,000 2.0000 150,000 2.0000 300,000

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

OTRKQ / Ontrak, Inc. Insider Trades
Insider Sales OTRKQ / Ontrak, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in BIVIW / BioVie Inc. - Equity Warrant. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Min		 Price at
Min		 Max Loss
Avoided ($)		 Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

OTRKQ / Ontrak, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Steve Gorlin as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change		 Share
Price		 Tran
Value		 Remaining
Value
2023-12-06 2023-12-01 4 BIVI BIOVIE INC.
Common Stock 		S - Sale -75,680 46,358 -62.01 1.69 -127,899 78,345
2023-12-06 2023-11-09 4 BIVI BIOVIE INC.
Common Stock 		A - Award 46,358 122,038 61.26
2023-09-07 2023-09-05 4 BIVI BIOVIE INC.
Common Stock 		S - Sale -8,560 75,680 -10.16 3.05 -26,108 230,824
2023-01-18 2022-11-23 4 BIVI BIOVIE INC.
COMMON STOCK 		A - Award 34,240 84,240 68.48
2022-04-20 2022-04-05 4 BIVI BIOVIE INC.
Stock Option (right to buy) 		A - Award 122,250 122,250
2021-03-05 2020-12-18 4 bivi BIOVIE INC.
options 		A - Award 96,300 96,300 13.91 1,339,533 1,339,533
2020-12-15 2020-11-03 4 BIVI BIOVIE INC.
Class A common stock, par value $0.0001 		P - Purchase 2,430 45,100 5.69 7.95 19,318 358,545
2020-12-15 2020-10-30 4 BIVI BIOVIE INC.
Class A common stock, par value $0.0001 		P - Purchase 2,570 42,670 6.41 7.97 20,483 340,080
2020-10-23 2020-06-16 5 bivi BIOVIE INC.
none 		U - Other 0 0
2020-10-22 2020-10-21 4 BIVI BIOVIE INC.
Class A common stock, par value $0.0001 		P - Purchase 5,000 40,100 14.25 9.19 45,950 368,519
2020-10-19 2020-10-15 4 BIVI BIOVIE INC.
Class A common stock, par value $0.0001 		P - Purchase 100 20,100 0.50 10.27 1,027 206,427
2020-10-19 2020-10-15 4 BIVI BIOVIE INC.
Class A common stock, par value $0.0001 		P - Purchase 1,000 21,100 4.98 10.18 10,180 214,798
2020-10-19 2020-10-15 4 BIVI BIOVIE INC.
Class A common stock, par value $0.0001 		P - Purchase 4,000 25,100 18.96 10.19 40,760 255,769
2020-10-19 2020-10-15 4 BIVI BIOVIE INC.
Class A common stock, par value $0.0001 		P - Purchase 5,000 30,100 19.92 10.10 50,500 304,010
2020-10-19 2020-10-15 4 BIVI BIOVIE INC.
Class A common stock, par value $0.0001 		P - Purchase 5,000 35,100 16.61 10.01 50,050 351,351
2020-10-14 2020-09-22 4 BIVI BIOVIE INC.
Class A common stock, par value $0.0001 		P - Purchase 15,000 15,000 10.00 150,000 150,000
2020-10-14 2020-10-07 4 BIVI BIOVIE INC.
Class A common stock, par value $0.0001 		P - Purchase 4,718 19,718 31.45 9.42 44,444 185,744
2020-10-14 2020-10-09 4 BIVI BIOVIE INC.
Class A common stock, par value $0.0001 		P - Purchase 282 20,000 1.43 9.61 2,710 192,200
2020-06-11 2020-06-10 4 NK NantKwest, Inc.
Stock Option (right to buy) 		A - Award 100,000 100,000
2019-08-08 2019-08-06 4 PTE POLARITYTE, INC.
Common Stock 		A - Award 29,718 31,018 2,286.00
2019-06-12 2019-06-10 4 PTE POLARITYTE, INC.
Common Stock 		S - Sale -53,700 1,300 -97.64 5.94 -318,978 7,722
2019-06-07 2019-06-06 4 NK NantKwest, Inc.
Common Stock 		A - Award 92,592 92,592
2018-12-03 2018-11-29 4 NK NantKwest, Inc.
Common Stock 		S - Sale -138,349 0 -100.00 1.65 -228,276
2018-11-29 2018-11-29 4 NK NantKwest, Inc.
Common Stock 		S - Sale -34,019 138,349 -19.74 1.70 -57,785 235,000
2018-11-29 2018-11-28 4 NK NantKwest, Inc.
Common Stock 		S - Sale -17,140 172,368 -9.04 1.76 -30,125 302,954
2018-11-29 2018-11-27 4 NK NantKwest, Inc.
Common Stock 		S - Sale -100,000 189,508 -34.54 1.75 -175,200 332,018
2018-11-26 2018-11-23 4 NK NantKwest, Inc.
Common Stock 		S - Sale -9,312 289,508 -3.12 2.01 -18,717 581,911
2018-11-26 2018-11-21 4 NK NantKwest, Inc.
Common Stock 		S - Sale -22,900 298,820 -7.12 2.02 -46,217 603,079
2018-11-14 2018-11-14 4 NK NantKwest, Inc.
Common Stock 		S - Sale -115,930 0 -100.00 2.21 -255,718
2018-11-14 2018-11-13 4 NK NantKwest, Inc.
Common Stock 		S - Sale -33,300 115,930 -22.31 2.40 -79,887 278,116
2018-11-14 2018-11-12 4 NK NantKwest, Inc.
Common Stock 		S - Sale -47,050 149,230 -23.97 2.43 -114,463 363,047
2018-11-05 2018-11-01 4 PTE POLARITYTE, INC.
Employee Stock Option (Right to Buy) 		A - Award 8,624 8,624
2018-11-05 2018-11-01 4 PTE POLARITYTE, INC.
Restricted Stock Units 		A - Award 4,020 4,020
2018-08-27 2018-08-27 4 NK NantKwest, Inc.
Common Stock 		S - Sale -18,300 196,280 -8.53 3.09 -56,463 605,602
2018-08-27 2018-08-24 4 NK NantKwest, Inc.
Common Stock 		S - Sale -10,225 214,580 -4.55 3.07 -31,341 657,709
2018-08-27 2018-08-23 4 NK NantKwest, Inc.
Common Stock 		S - Sale -21,475 224,805 -8.72 3.06 -65,709 687,858
2018-06-18 2018-06-15 4 CATS CATASYS, INC.
Common Stock 		P - Purchase 215 100,000 0.22 8.57 1,843 857,000
2018-06-18 2018-06-15 4 CATS CATASYS, INC.
Common Stock 		P - Purchase 2,300 99,785 2.36 8.59 19,757 857,153
2018-06-18 2018-06-15 4 CATS CATASYS, INC.
Common Stock 		P - Purchase 300 97,485 0.31 8.65 2,595 843,245
2018-06-18 2018-06-15 4 CATS CATASYS, INC.
Common Stock 		P - Purchase 1,550 97,185 1.62 8.60 13,330 835,791
2018-06-18 2018-06-15 4 CATS CATASYS, INC.
Common Stock 		P - Purchase 100 95,635 0.10 8.64 864 826,286
2018-06-18 2018-06-15 4 CATS CATASYS, INC.
Common Stock 		P - Purchase 300 95,535 0.32 8.59 2,577 820,646
2018-06-18 2018-06-15 4 CATS CATASYS, INC.
Common Stock 		P - Purchase 1,700 95,235 1.82 8.68 14,756 826,640
2018-06-18 2018-06-15 4 CATS CATASYS, INC.
Common Stock 		P - Purchase 300 93,535 0.32 8.63 2,589 807,207
2018-06-18 2018-06-15 4 CATS CATASYS, INC.
Common Stock 		P - Purchase 700 93,235 0.76 8.69 6,083 810,212
2018-06-18 2018-06-15 4 CATS CATASYS, INC.
Common Stock 		P - Purchase 3,000 92,535 3.35 8.70 26,100 805,054
2018-06-18 2018-06-15 4 CATS CATASYS, INC.
Common Stock 		P - Purchase 200 89,535 0.22 8.67 1,734 776,268
2018-06-18 2018-06-15 4 CATS CATASYS, INC.
Common Stock 		P - Purchase 1,100 89,335 1.25 8.71 9,581 778,108
2018-06-18 2018-06-15 4 CATS CATASYS, INC.
Common Stock 		P - Purchase 100 88,235 0.11 8.63 863 761,468
2018-06-18 2018-06-15 4 CATS CATASYS, INC.
Common Stock 		P - Purchase 200 88,135 0.23 8.58 1,716 756,198
2018-06-18 2018-06-15 4 CATS CATASYS, INC.
Common Stock 		P - Purchase 350 87,935 0.40 8.50 2,975 747,448
2018-06-18 2018-06-15 4 CATS CATASYS, INC.
Common Stock 		P - Purchase 100 87,585 0.11 8.45 845 740,093
2018-06-18 2018-06-15 4 CATS CATASYS, INC.
Common Stock 		P - Purchase 1,385 87,485 1.61 8.49 11,759 742,748
2018-06-18 2018-06-15 4 CATS CATASYS, INC.
Common Stock 		P - Purchase 1,100 86,100 1.29 8.47 9,317 729,267
2018-06-18 2018-06-15 4 CATS CATASYS, INC.
Common Stock 		P - Purchase 115 85,000 0.14 8.49 976 721,650
2018-06-18 2018-06-15 4 CATS CATASYS, INC.
Common Stock 		P - Purchase 85 84,885 0.10 8.48 721 719,825
2018-06-18 2018-06-15 4 CATS CATASYS, INC.
Common Stock 		P - Purchase 900 84,800 1.07 8.46 7,614 717,408
2018-06-18 2018-06-15 4 CATS CATASYS, INC.
Common Stock 		P - Purchase 200 83,900 0.24 8.45 1,690 708,955
2018-06-18 2018-06-15 4 CATS CATASYS, INC.
Common Stock 		P - Purchase 600 83,700 0.72 8.50 5,100 711,450
2018-06-18 2018-06-15 4 CATS CATASYS, INC.
Common Stock 		P - Purchase 200 83,100 0.24 8.47 1,694 703,857
2018-06-18 2018-06-15 4 CATS CATASYS, INC.
Common Stock 		P - Purchase 100 82,900 0.12 8.41 841 697,189
2018-06-18 2018-06-15 4 CATS CATASYS, INC.
Common Stock 		P - Purchase 800 82,800 0.98 8.40 6,720 695,520
2018-06-18 2018-06-15 4 CATS CATASYS, INC.
Common Stock 		P - Purchase 1,000 82,000 1.23 8.39 8,390 687,980
2018-06-18 2018-06-15 4 CATS CATASYS, INC.
Common Stock 		P - Purchase 100 81,000 0.12 8.38 838 678,780
2018-06-18 2018-06-15 4 CATS CATASYS, INC.
Common Stock 		P - Purchase 800 80,900 1.00 8.35 6,680 675,515
2018-06-18 2018-06-15 4 CATS CATASYS, INC.
Common Stock 		P - Purchase 100 80,100 0.12 8.34 834 668,034
2018-06-18 2018-06-15 4 CATS CATASYS, INC.
Common Stock 		P - Purchase 300 80,000 0.38 7.95 2,385 636,000
2018-06-18 2018-06-15 4 CATS CATASYS, INC.
Common Stock 		P - Purchase 1,200 79,700 1.53 7.91 9,492 630,427
2018-06-18 2018-06-15 4 CATS CATASYS, INC.
Common Stock 		P - Purchase 2,200 78,500 2.88 7.94 17,468 623,290
2018-06-18 2018-06-15 4 CATS CATASYS, INC.
Common Stock 		P - Purchase 600 76,300 0.79 7.91 4,746 603,533
2018-06-18 2018-06-15 4 CATS CATASYS, INC.
Common Stock 		P - Purchase 600 75,700 0.80 7.93 4,758 600,301
2018-06-18 2018-06-15 4 CATS CATASYS, INC.
Common Stock 		P - Purchase 100 75,100 0.13 7.92 792 594,792
2018-06-07 2018-06-07 4 NK NantKwest, Inc.
Common Stock 		S - Sale -26,957 321,720 -7.73 3.66 -98,614 1,176,916
2018-06-07 2018-06-06 4 NK NantKwest, Inc.
Common Stock 		S - Sale -23,574 348,677 -6.33 3.79 -89,272 1,320,405
2018-06-07 2018-06-05 4 NK NantKwest, Inc.
Common Stock 		S - Sale -28,925 372,251 -7.21 3.75 -108,339 1,394,266
2018-06-01 2018-05-30 4 NK NantKwest, Inc.
Common Stock 		S - Sale -2,724 401,176 -0.67 3.88 -10,564 1,555,801
2018-05-29 2018-05-29 4 NK NantKwest, Inc.
Common Stock 		S - Sale -100 403,900 -0.02 3.90 -390 1,573,190
2018-05-29 2018-05-29 4 NK NantKwest, Inc.
Common Stock 		S - Sale -500 404,000 -0.12 3.90 -1,950 1,575,600
2018-05-29 2018-05-29 4 NK NantKwest, Inc.
Common Stock 		S - Sale -1,500 404,500 -0.37 3.89 -5,835 1,573,505
2018-05-29 2018-05-25 4 NK NantKwest, Inc.
Common Stock 		S - Sale -200 406,000 -0.05 3.98 -796 1,615,880
2018-05-29 2018-05-25 4 NK NantKwest, Inc.
Common Stock 		S - Sale -3,400 406,200 -0.83 3.97 -13,498 1,612,614
2018-05-29 2018-05-24 4 NK NantKwest, Inc.
Common Stock 		S - Sale -303 409,600 -0.07 3.96 -1,200 1,622,016
2018-05-24 2018-05-22 4/A NK NantKwest, Inc.
Common Stock 		S - Sale -8,546 409,903 -2.04 3.91 -33,431 1,603,500
2018-05-24 2018-05-21 4/A NK NantKwest, Inc.
Common Stock 		S - Sale -5,557 418,449 -1.31 4.00 -22,217 1,672,959
2018-05-23 2018-05-22 4 NK NantKwest, Inc.
Common Stock 		S - Sale -8,546 409,903 -2.04 3.81 -32,560 1,561,730
2018-05-23 2018-05-21 4 NK NantKwest, Inc.
Common Stock 		S - Sale -5,557 418,449 -1.31 3.90 -21,672 1,631,951
2018-05-22 2018-05-18 4 NK NantKwest, Inc.
Common Stock 		S - Sale -15,971 424,006 -3.63 3.97 -63,413 1,683,516
2018-05-17 2018-05-17 4 NK NantKwest, Inc.
Common Stock 		S - Sale -38,708 439,977 -8.09 4.00 -154,929 1,761,008
2018-05-17 2018-05-16 4 NK NantKwest, Inc.
Common Stock 		S - Sale -16,200 478,685 -3.27 4.05 -65,634 1,939,392
2018-05-17 2018-05-15 4 NK NantKwest, Inc.
Common Stock 		S - Sale -26,835 494,885 -5.14 4.13 -110,890 2,045,013
2017-12-22 2017-12-19 4 CATS CATASYS, INC.
Stock Option to purchase Common Stock 		A - Award 52,836 52,836
2017-11-13 2017-11-10 4 COOL POLARITYTE, INC.
Option 		A - Award 5,000 416 -109.08
2017-11-13 2017-11-10 4 COOL POLARITYTE, INC.
Common stock, par value $0.001 per share 		A - Award 5,000 23,333 27.27
2017-11-01 2017-10-30 4 MDVX Medovex Corp.
Common Stock 		A - Award 10,684 1,640,704 0.66 1.17 12,500 1,919,624
2017-09-13 2017-09-13 4 NK NantKwest, Inc.
Common Stock 		S - Sale -39,604 246,280 -13.85 5.93 -234,729 1,459,677
2017-09-12 2017-09-12 4 NK NantKwest, Inc.
Common Stock 		S - Sale -35,811 285,884 -11.13 6.03 -215,833 1,723,023
2017-09-12 2017-09-11 4 NK NantKwest, Inc.
Common Stock 		S - Sale -53,307 321,695 -14.22 6.03 -321,468 1,939,982
2017-09-12 2017-09-08 4 NK NantKwest, Inc.
Common Stock 		S - Sale -14,723 375,002 -3.78 6.12 -90,117 2,295,312
2017-08-22 2017-08-21 4 MDVX Medovex Corp.
Common Stock 		P - Purchase 50,000 1,630,020 3.16 1.25 62,500 2,037,525
2017-08-16 2017-08-16 4 MDVX Medovex Corp.
Common Stock 		P - Purchase 200,000 1,580,020 14.49 0.90 180,000 1,422,018
2017-06-29 2017-06-28 4 MDVX Medovex Corp.
Common Stock 		P - Purchase 2,000 1,380,020 0.15 0.88 1,760 1,214,418
2017-06-29 2017-06-28 4 MDVX Medovex Corp.
Common Stock 		P - Purchase 3,000 1,378,020 0.22 0.87 2,610 1,198,877
2017-06-21 2017-06-20 4 NK NantKwest, Inc.
Common Stock 		S - Sale X -20,000 389,725 -4.88 8.13 -162,600 3,168,464
2017-06-21 2017-06-20 4 NK NantKwest, Inc.
Common Stock 		S - Sale X -20,000 409,725 -4.65 7.43 -148,600 3,044,257
2017-06-15 2017-06-14 4 MDVX Medovex Corp.
Common Stock 		P - Purchase 5,000 1,375,020 0.36 0.97 4,850 1,333,769
2017-06-08 2017-06-07 4 MDVX Medovex Corp.
Common Stock 		P - Purchase 5,000 1,370,020 0.37 0.98 4,900 1,342,620
2017-06-08 2017-06-07 4 MDVX Medovex Corp.
Common Stock 		P - Purchase 5,000 1,365,020 0.37 0.96 4,800 1,310,419
2017-06-08 2017-06-07 4 MDVX Medovex Corp.
Common Stock 		P - Purchase 15,000 1,360,020 1.12 0.95 14,250 1,292,019
2017-06-08 2017-06-07 4 MDVX Medovex Corp.
Common Stock 		P - Purchase 5,000 1,345,020 0.37 0.94 4,700 1,264,319
2017-02-22 2017-02-17 4 MDVX Medovex Corp.
Warrants 		P - Purchase 19,179 79,179 31.96 0.35 6,713 27,713
2017-02-22 2017-02-17 4 MDVX Medovex Corp.
Warrants 		P - Purchase 60,000 60,000 0.36 21,600 21,600
2017-02-15 3 COOL POLARITYTE, INC.
Common Stock 		100,000
2017-02-15 3 COOL POLARITYTE, INC.
Common Stock 		100,000
2017-02-14 2017-02-09 4 MDVX Medovex Corp.
Warrants 		P - Purchase 72,115 459,615 18.61 1.04 75,000 478,000
2017-02-14 2017-02-09 4 MDVX Medovex Corp.
Common Stock 		P - Purchase 144,230 1,340,020 12.06 1.04 149,999 1,393,621
2017-02-10 2016-10-07 5 NK NantKwest, Inc.
Common Stock 		G - Gift 300,000 521,720 135.31
2017-02-10 2016-10-07 5 NK NantKwest, Inc.
Common Stock 		G - Gift -300,000 429,725 -41.11
2016-12-06 2016-12-01 4 MDVX Medovex Corp.
Warrants 		P - Purchase -112,500 387,500 -22.50
2016-12-06 2016-12-01 4 MDVX Medovex Corp.
Common Stock 		P - Purchase 314,286 1,018,592 44.62 1.75 550,000 1,782,536
2016-12-06 2016-12-01 4 MDVX Medovex Corp.
Common Stock 		P - Purchase -257,143 704,360 -26.74 1.75 -450,000 1,232,630
2016-05-25 2016-05-23 4 NK NantKwest, Inc.
Stock Option (right to buy) 		M - Exercise -324,012 0 -100.00
2016-05-25 2016-05-23 4 NK NantKwest, Inc.
Common Stock 		M - Exercise 324,012 729,725 79.86 0.22 70,019 157,694
2016-02-18 2016-02-16 4 MDVX Medovex Corp.
Common Stock 		P - Purchase 552,041 961,503 134.82 1.81 999,967 1,741,667
2016-02-16 2015-12-28 5 NK NantKwest, Inc.
Common Stock 		G - Gift -50,000 405,713 -10.97
2015-12-18 2015-12-10 4 MDVX Medovex Corp.
Common Stock 		P - Purchase 20,000 409,462 5.14 1.09 21,750 445,290
2015-12-18 2015-12-09 4 MDVX Medovex Corp.
Common Stock 		P - Purchase 20,000 389,462 5.41 1.15 22,918 446,285
2015-11-30 2015-11-24 4 MDVX Medovex Corp.
Common Stock 		P - Purchase 40,000 369,462 12.14 1.45 57,960 535,350
2015-11-30 2015-11-09 4 MDVX Medovex Corp.
Warrants 		P - Purchase 500,000 0 -100.00 1,100,000.00 550,000,000,000
2015-11-30 2015-11-09 4 MDVX Medovex Corp.
Convertible Note 		P - Purchase 1 1 2,000,000.00 2,000,000 2,000,000
2015-10-20 2015-10-16 4 CATS CATASYS, INC.
Common Stock, par value $0.0001 per share 		P - Purchase 300,000 450,000 200.00 0.30 90,000 135,000
2015-08-25 2015-08-21 4 NK NantKwest, Inc.
Common Stock 		S - Sale -450,000 221,720 -66.99 23.00 -10,350,000 5,099,560
2015-07-27 3 NK NantKwest, Inc.
Common Stock 		1,583,146
2015-07-27 3 NK NantKwest, Inc.
Common Stock 		1,799,153
2015-07-27 3 NK NantKwest, Inc.
Common Stock 		1,583,146
2015-07-27 3 NK NantKwest, Inc.
Common Stock 		1,799,153
2015-04-28 2015-02-17 4 CATS CATASYS, INC.
Stock Option to purchase Common Stock 		A - Award 200,000 200,000
2015-04-28 2014-12-22 4 CATS CATASYS, INC.
Common Stock, par value $0.0001 per share 		P - Purchase 150,000 150,000 2.00 300,000 300,000
2015-02-02 3 MDVX Medovex Corp.
Common Stock 		709,828
2015-02-02 3 MDVX Medovex Corp.
Common Stock 		542,414
2015-02-02 3 MDVX Medovex Corp.
Common Stock 		709,828
2015-02-02 3 MDVX Medovex Corp.
Common Stock 		542,414
2013-05-30 2013-05-16 4 MDXG MIMEDX GROUP, INC.
Common Stock 		S - Sale -30,000 451,857 -6.23 6.46 -193,800 2,918,996
2013-05-13 2013-05-09 4 MDXG MIMEDX GROUP, INC.
Stock Option 		A - Award 15,000 140,000 12.00 6.60 99,000 924,000
2013-05-13 2013-05-09 4 MDXG MIMEDX GROUP, INC.
Restricted Common Stock 		A - Award 5,000 16,500 43.48 6.60 33,000 108,900
2013-04-19 2013-04-17 4 MDXG MIMEDX GROUP, INC.
Common Stock 		S - Sale -20,000 481,857 -3.99 4.99 -99,800 2,404,466
2012-11-06 2012-11-06 4 MDXG MIMEDX GROUP, INC.
Common Stock 		S - Sale -22,700 501,857 -4.33 2.89 -65,603 1,450,367
2012-11-06 2012-11-05 4 MDXG MIMEDX GROUP, INC.
Common Stock 		S - Sale -8,550 524,557 -1.60 2.87 -24,538 1,505,479
2012-11-06 2012-11-05 4 MDXG MIMEDX GROUP, INC.
Common Stock 		S - Sale -18,450 533,107 -3.35 2.89 -53,320 1,540,679
2012-11-06 2012-11-05 4 MDXG MIMEDX GROUP, INC.
Common stock 		S - Sale -12,000 551,557 -2.13 2.90 -34,800 1,599,515
2012-11-06 2012-11-02 4 MDXG MIMEDX GROUP, INC.
Common Stock 		S - Sale -3,300 563,557 -0.58 2.86 -9,438 1,611,773
2012-11-06 2012-11-02 4 MDXG MIMEDX GROUP, INC.
Common Stock 		S - Sale -15,000 566,857 -2.58 2.88 -43,200 1,632,548
2012-11-06 2012-11-02 4 MDXG MIMEDX GROUP, INC.
Common Stock 		S - Sale -20,000 581,857 -3.32 2.90 -58,000 1,687,385
2012-11-02 2012-10-31 4 MDXG.OB MIMEDX GROUP, INC.
Stock Option 		A - Award 15,000 125,000 13.64 2.94 44,100 367,500
2012-09-12 2012-09-10 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		S - Sale -72,300 11,500 -86.28 2.70 -195,210 31,050
2012-07-03 2012-06-29 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		S - Sale -1,000,000 601,857 -62.43 1.55 -1,550,000 932,878
2012-05-17 2012-05-15 4 DARA DARA BioSciences, Inc.
Stock Option(right to buy) 		A - Award 50,000 50,000
2012-03-05 2012-03-02 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		S - Sale -250,000 1,601,857 -13.50 1.00 -250,000 1,601,857
2011-12-19 2011-12-14 4 MDXG.OB MIMEDX GROUP, INC.
Stock Option 		A - Award 15,000 110,000 15.79 1.10 16,500 121,000
2010-05-14 2010-05-11 4 MDXG.OB MIMEDX GROUP, INC.
Stock Option 		A - Award 15,000 15,000
2010-04-02 2010-04-01 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		P - Purchase 2,000 83,800 2.44 1.52 3,040 127,376
2010-04-02 2010-04-01 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		P - Purchase 2,500 81,800 3.15 1.50 3,750 122,700
2010-04-02 2010-04-01 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		P - Purchase 500 79,300 0.63 1.45 725 114,985
2010-04-01 2010-03-30 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		P - Purchase 2,000 78,800 2.60 1.57 3,140 123,716
2010-04-01 2010-03-30 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		P - Purchase 2,000 76,800 2.67 1.55 3,100 119,040
2010-03-29 2010-03-26 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		P - Purchase 1,000 74,800 1.36 1.57 1,570 117,436
2009-12-11 2009-12-10 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		P - Purchase 200 443,186 0.05 0.68 136 301,366
2009-12-11 2009-12-09 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		P - Purchase 200 442,986 0.05 0.70 140 310,090
2009-12-09 2009-12-08 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		P - Purchase 500 442,786 0.11 0.65 325 287,811
2009-12-09 2009-12-07 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		P - Purchase 2,500 442,286 0.57 0.70 1,750 309,600
2009-12-09 2009-12-07 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		P - Purchase 5,000 439,786 1.15 0.65 3,250 285,861
2009-11-20 2009-11-19 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		P - Purchase 35,000 2,190,987 1.62 0.50 17,500 1,095,494
2009-11-09 2009-11-06 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		P - Purchase 500 73,800 0.68 0.78 390 57,564
2009-11-09 2009-11-05 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		P - Purchase 500 73,300 0.69 0.78 390 57,174
2009-10-26 2009-10-23 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		P - Purchase 500 72,800 0.69 0.80 400 58,240
2009-10-26 2009-10-22 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		P - Purchase 500 72,300 0.70 0.80 400 57,840
2009-10-02 2009-10-02 4 MDXG.OB MIMEDX GROUP, INC.
Comon Stock 		P - Purchase 11,500 71,800 19.07 0.85 9,775 61,030
2009-10-02 2009-10-02 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		P - Purchase 6,000 60,300 11.05 0.80 4,800 48,240
2009-10-02 2009-10-02 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		P - Purchase 500 54,300 0.93 0.75 375 40,725
2009-10-02 2009-10-01 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		P - Purchase 500 53,800 0.94 0.75 375 40,350
2009-10-02 2009-09-30 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		P - Purchase 6,100 53,300 12.92 0.75 4,575 39,975
2009-09-29 2009-09-29 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		P - Purchase 4,000 47,200 9.26 0.75 3,000 35,400
2009-09-29 2009-09-28 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		P - Purchase 1,000 43,200 2.37 0.75 750 32,400
2009-09-29 2009-09-25 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		P - Purchase 1,500 42,200 3.69 0.75 1,125 31,650
2009-09-25 2009-09-24 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		P - Purchase 2,500 40,700 6.54 0.69 1,725 28,083
2009-09-25 2009-09-23 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		P - Purchase 3,200 38,200 9.14 0.70 2,240 26,740
2009-09-23 2009-09-22 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		P - Purchase 3,000 35,000 9.38 0.70 2,100 24,500
2009-09-23 2009-09-21 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		P - Purchase 2,500 32,000 8.47 0.70 1,750 22,400
2009-09-21 2009-09-18 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		P - Purchase 2,500 29,500 9.26 0.70 1,750 20,650
2009-09-18 2009-09-18 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		P - Purchase 1,000 27,000 3.85 0.70 700 18,900
2009-09-18 2009-09-17 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		P - Purchase 2,416 26,000 10.24 0.60 1,450 15,600
2009-09-18 2009-09-17 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		P - Purchase 1,000 23,584 4.43 0.59 590 13,915
2009-09-18 2009-09-16 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		P - Purchase 1,000 22,584 4.63 0.60 600 13,550
2009-09-15 2009-09-15 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		P - Purchase 12,400 21,584 135.02 0.60 7,440 12,950
2009-09-14 2009-09-14 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		P - Purchase 7,500 9,184 445.37 0.60 4,500 5,510
2009-09-11 2009-09-10 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		P - Purchase 1,000 1,684 146.20 0.60 600 1,010
2009-09-11 2009-09-09 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		P - Purchase 184 684 36.80 0.45 83 308
2009-09-11 2009-09-09 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		P - Purchase 500 500 0.60 300 300
2009-09-01 2009-08-28 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		G - Gift 34,786 434,786 8.70
2009-09-01 2009-08-28 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		G - Gift -34,786 0 -100.00
2009-09-01 2009-08-28 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		G - Gift -25,000 34,786 -41.82
2009-09-01 2009-08-28 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		A - Award 59,786 59,786 0.50 29,893 29,893
2009-08-07 2009-08-04 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock 		S - Sale -450,504 2,155,987 -17.28
2008-02-12 2008-02-08 4 AYXC.OB Alynx, Co.
Stock option 		A - Award 247,314 247,314
2008-02-12 2008-02-08 4 AYXC.OB Alynx, Co.
Common Stock 		A - Award 1,236,568 10,530,844 13.30
2008-02-12 2008-02-08 4 AYXC.OB Alynx, Co.
Common Stock 		A - Award 1,236,568 10,530,844 13.30
2008-02-12 2008-02-08 4 AYXC.OB Alynx, Co.
Common Stock 		A - Award 8,057,708 10,530,844 325.81
2008-02-12 3 AYXC.OB Alynx, Co.
Common Stock 		8,057,708
2008-02-12 3 AYXC.OB Alynx, Co.
Common Stock 		1,236,568
2008-02-12 3 AYXC.OB Alynx, Co.
Common Stock 		1,236,568
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)